Scarica l'app Stockscreener
1.58
10.23%
-0.18
Pre-mercato:
1.68
0.10
+6.33%
Precedente Chiudi:
$1.76
Aprire:
$1.74
Volume 24 ore:
3.59M
Relative Volume:
1.74
Capitalizzazione di mercato:
$109.46M
Reddito:
$149.16M
Utile/perdita netta:
$-39.14M
Rapporto P/E:
-2.6439
EPS:
-0.5976
Flusso di cassa netto:
$-21.18M
1 W Prestazione:
+8.97%
1M Prestazione:
+14.49%
6M Prestazione:
-45.70%
1 anno Prestazione:
-55.49%
Intervallo 1D:
$1.50
$1.81
Intervallo di 1 settimana:
$1.405
$1.815
Portata 52W:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Nome
Neuronetics Inc
Settore
Industria
Telefono
877-600-7555
Indirizzo
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.58 | 109.46M | 149.16M | -39.14M | -21.18M | -0.5976 |
ABT
Abbott Laboratories
|
101.83 | 176.95B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.07 | 127.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.42 | 110.95B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
61.86 | 91.93B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.84 | 46.61B | 6.07B | 1.06B | 1.34B | 1.8063 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2018-07-24 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Neuronetics Inc Borsa (STIM) Ultime notizie
Top shareholder says Neuronetics has 'chronically underperformed,’ pushes sale review - The Business Journals
Neuronetics responds to shareholder letter on valuation By Investing.com - Investing.com India
Neuronetics responds to shareholder letter on valuation - Investing.com
Neuronetics Comments on Letter from Pointillist Family Office - Yahoo Finance
Neuronetics Announces Chief Financial Officer Transition - National Today
Neuronetics CFO Transition Announced; Company Reaffirms 2026 Financial Guidance and Focus on NeuroStar Advanced Therapy 1 - Minichart
Neuronetics CFO Steven Pfanstiel to depart in May By Investing.com - Investing.com Canada
Aug Outlook: Is Neuronetics Inc stock a buy or sellEarnings Beat & Community Trade Idea Sharing Platform - baoquankhu1.vn
Neuronetics (STIM) CFO Steven Pfanstiel to Step Down - GuruFocus
STIM Maintains FY26 Financial Outlook with Key Projections - GuruFocus
Neuronetics (STIM) Reaffirms Financial Guidance Amid New Announcement - GuruFocus
Neuronetics (STIM) Shareholder Pushes for Strategic Alternatives Review - GuruFocus
Neuronetics CFO Steven Pfanstiel to depart; company begins search for successor - MSN
Neuronetics largest shareholder pushes for strategic review By Investing.com - Investing.com Australia
Neuronetics Announces CFO Transition and Reaffirms 2026 Outlook - TipRanks
Neuronetics Inc. announced that its Chief Financial Officer and Treasurer, Steven E. Furlansteir, has decided to step down. - Bitget
Neuronetics Inc initiates workforce reduction impacting up to 5% of employees - marketscreener.com
Neuronetics announces chief financial officer transition - marketscreener.com
Neuronetics Inc Initiates Workforce Reduction Impacting Up To 5% Of Employees - TradingView
Neuronetics Announces CFO Exit, Reaffirms Financial Guidance - marketscreener.com
Neuronetics, Inc. Announces Departure of CFO Steven E. Pfanstiel, Confirms Financial Guidance - Quiver Quantitative
CFO exit and cost cuts at Neuronetics (NASDAQ: STIM) 2026 - Stock Titan
Neuronetics, Inc. Announces to Depart Steven E. Pfanstiel as Chief Financial Officer, Effective May 1, 2026 - marketscreener.com
Largest Independent Shareholder of Neuronetics, Inc., Jorey Chernett, Calls for Immediate and Comprehensive Review of Strategic Alternatives, Including Sale of TMS Business - Stock Titan
Neuronetics, Inc. (STIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
How The Neuronetics (STIM) Story Is Shifting As Analysts Rework Valuation Assumptions - Yahoo Finance
Madryn funds shift 674,624 Neuronetics (STIM) shares between vehicles - Stock Titan
Jorey Chernett reports 14.1% Neuronetics (STIM) holding in 13D - Stock Titan
Insider Buying: Jorey Chernett Acquires 385,442 Shares of Neuron - GuruFocus
Neuronetics appoints Dan Reuvers as CEO, succeeding Keith Sullivan - MSN
Neuronetics to report fourth quarter 2025 results March 17 - MSN
Chernett buys Neuronetics (STIM) shares worth $481,802 By Investing.com - Investing.com South Africa
Chernett buys Neuronetics (STIM) shares worth $481,802 - investing.com
Ten percent owner Jorey Chernett boosts Neuronetics (STIM) stake with 385K-share buy - Stock Titan
Insider Buying: Jorey Chernett Acquires 500,000 Shares of Neuron - GuruFocus
Chernett Jorey buys Neuronetics (STIM) shares worth $675,000 By Investing.com - Investing.com Australia
Neuronetics Insider Bought Shares Worth $675,000, According to a Recent SEC Filing - marketscreener.com
Chernett Jorey buys Neuronetics (STIM) shares worth $675,000 - investing.com
Neuronetics 10% Owner Purchased Shares Worth Over $675K - TradingView
[Form 4] Neuronetics, Inc. Insider Trading Activity - Stock Titan
Aug Rallies: Does Neuronetics Inc have a competitive edge2026 Valuation Update & Scalable Portfolio Growth Ideas - baoquankhu1.vn
Neuronetics (STIM) price target decreased by 53.85% to 3.06 - MSN
Insider Buying: Jorey Chernett Acquires 150,000 Shares of Neuron - GuruFocus
Chernett Jorey buys Neuronetics (STIM) shares worth $211,000 - Investing.com
Chernett Jorey buys Neuronetics (STIM) shares worth $211,000 By Investing.com - Investing.com Australia
Neuronetics (STIM) 10% owner Jorey Chernett buys 150,000 shares - Stock Titan
Neuronetics Reports Higher Revenue, Narrows Loss, Sets 2026 Outlook - MyChesCo
Neuronetics (NASDAQ:STIM) Director Sells $62,027.26 in Stock - MarketBeat
Neuronetics (NASDAQ:STIM) EVP Sells $21,446.70 in Stock - MarketBeat
Neuronetics Inc Azioni (STIM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.44%
0.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):